For the quarter ending 2025-09-30, TXMD has $38,671K in assets. $11,227K in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,115 | 6,069 | ||
| Royalty receivable, current portion | 3,665 | 3,743 | ||
| Prepaid and other current assets | 3,723 | 3,649 | ||
| Total current assets | 14,503 | 13,461 | ||
| License rights and other intangible assets, net | 3,914 | 4,043 | ||
| Right of use assets | 5,515 | 5,732 | ||
| Royalty receivable, long term | 14,269 | 14,840 | ||
| Other non-current assets | 470 | 428 | ||
| Total assets | 38,671 | 38,504 | ||
| Accounts payable | 263 | 350 | ||
| Accrued expenses and other current liabilities | 2,015 | 1,590 | ||
| Current liabilities of discontinued operations | 2,667 | 2,722 | ||
| Total current liabilities | 4,945 | 4,662 | ||
| Operating lease liabilities | 5,411 | 5,718 | ||
| Other non-current liabilities | 871 | 832 | ||
| Total liabilities | 11,227 | 11,212 | ||
| Common stock, par value 0.001 32,000 shares authorized, 11,574 and 11,532 issued and outstanding as of september 30, 2025 and december 31, 2024 | 11 | 11 | ||
| Additional paid-in capital | 979,205 | 979,205 | ||
| Accumulated deficit | -951,772 | -951,924 | ||
| Total stockholders equity | 27,444 | 27,292 | ||
| Total liabilities and stockholders equity | 38,671 | 38,504 | ||
TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. (TXMD)